← All stocks

Privia Health Group, Inc.

PRVA Net selling
CIK 0001759655 #1824 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.24M
$5.95M on a plan · $13.45M straight out of an exercise
Sold at will
$2.84M
12 of 40 sales
Net
−$22.24M
−$2.84M against sales at will

By person

14 insiders · 40 transactions
18.4×

Parth Mehrotra holds 18.4 times base salary in stock. $12.02M of shares against $650.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Parth Mehrotra last reported holding, valued at $27.67, the price Common Stock, par value $0.01 per share was last bought or sold at on the open market here, on 9 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Morris Matthew Shawn
Director
$11.88M (12) scheduled
−$11.88M
68,188
0.0534%
$1.89M
+10.6%
Mehrotra Parth
Chief Executive Officer
$6.43M (10) scheduled
−$6.43M
434,357
0.3400%
$12.02M
+19.0%
Mountcastle David
EVP & Chief Financial Officer
$3.72M (16) scheduled
−$3.72M
164,853
0.1291%
$4.56M
−36.0%
Fargis Edward C
EVP & General Counsel
$214.76K (2)
−$214.76K
111,979
0.0877%
$3.10M
+53.5%
KING DAVID P
Director
50,775
0.0398%
$1.40M
+49.7%
Ryu Jaewon
Director
47,110
0.0369%
$1.30M
+55.7%
COCOZZA NANCY G
Director
42,814
0.0335%
$1.18M
+65.0%
Maryland Patricia Anne
Director
42,312
0.0331%
$1.17M
+24.8%
Kimmet Pamela O
Director
34,172
0.0268%
$945.54K
+97.4%
McCarthy Thomas A
Director
27,983
0.0219%
$774.29K
+151.6%
WICHMANN DAVID S
Director
25,709
0.0201%
$711.37K
+48.5%
BERBERIAN LANCE
Director
16,131
0.0126%
$446.34K
SOISTMAN FRANCIS S JR
Director
8,463
0.0066%
$234.17K
Ernest Opella Finley
Director
6,350
0.0050%
$175.70K
Insider
Date
Role
Action
Shares
Price
Amount
Morris Matthew Shawn
6 Jul 2026
Director
Sold after exercise
53,722
$27.24
$1.46M
Morris Matthew Shawn
2 Jul 2026
Director
Sold after exercise
59,037
$27.33
$1.61M
Morris Matthew Shawn
1 Jul 2026
Director
Sold after exercise
37,041
$26.93
$997.51K
Morris Matthew Shawn
1 Jul 2026
Director
Sold after exercise
45,634
$26.52
$1.21M
Morris Matthew Shawn
30 Jun 2026
Director
Sold after exercise
52,823
$25.72
$1.36M
Morris Matthew Shawn
29 Jun 2026
Director
Sold after exercise
63,212
$25.33
$1.60M
Mountcastle David
26 Jun 2026
EVP & Chief Financial Officer
Sold after exercise
17,196
$25.18
$433.00K
Morris Matthew Shawn
26 Jun 2026
Director
Sold after exercise
88,110
$25.33
$2.23M
Morris Matthew Shawn
4 May 2026
Director
Sold after exercise
1,017
$24.96
$25.38K
Mountcastle David
4 May 2026
EVP & Chief Financial Officer
Sold after exercise
1,206
$25.00
$30.15K
Morris Matthew Shawn
1 May 2026
Director
Sold after exercise
17,096
$24.99
$427.23K
Mountcastle David
1 May 2026
EVP & Chief Financial Officer
Sold after exercise
7,179
$25.03
$179.69K
Mountcastle David
27 Feb 2026
EVP & Chief Financial Officer
Sold after exercise
7,697
$25.05
$192.81K
Morris Matthew Shawn
27 Feb 2026
Director
Sold after exercise
16,550
$25.00
$413.75K
Mountcastle David
26 Feb 2026
EVP & Chief Financial Officer
Sold after exercise
5,361
$25.00
$134.03K
Morris Matthew Shawn
26 Feb 2026
Director
Sold after exercise
7,788
$24.99
$194.62K
Mountcastle David
12 Dec 2025
EVP & Chief Financial Officer
Sold after exercise
23,887
$25.03
$597.89K
Morris Matthew Shawn
12 Dec 2025
Director
Sold after exercise
13,647
$25.01
$341.31K

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 18
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 1,011,690
History held since 30 Apr 2021